Akebia Therapeutics Inc. buy HC Wainwright
Start price
17.11.23
/
50%
€0.92
Target price
17.11.24
€4.60
Performance (%)
48.64%
Price
11:05
€1.35
Summary
This prediction is currently active. With a performance of 48.64% the BUY prediction by HC_Wainwright is a big success. This prediction currently runs until 17.11.24. The prediction end date can be changed by HC_Wainwright at any time. HC_Wainwright has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Akebia Therapeutics Inc. | 8.540% | 8.540% |
iShares Core DAX® | 1.280% | 1.027% |
iShares Nasdaq 100 | -2.457% | -4.650% |
iShares Nikkei 225® | -2.006% | -2.091% |
iShares S&P 500 | -0.662% | -1.246% |
Comments by HC_Wainwright for this prediction
In the thread Akebia Therapeutics Inc. diskutieren
Akebia Therapeutics, Inc. (NASDAQ: AKBA) had its price target raised by analysts at HC Wainwright from $3.75 to $5.00. They now have a "buy" rating on the stock.
Ratings data for AKBA provided by MarketBeat
Stopped prediction by HC_Wainwright for Akebia Therapeutics Inc.
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.82
28.03.24
28.03.24
€5.55
28.03.25
28.03.25
-25.99%
11:05
11:05
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.11
27.09.23
27.09.23
€3.55
27.09.24
27.09.24
22.30%
11:05
11:05
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.27
28.08.23
28.08.23
€3.47
28.08.24
28.08.24
7.09%
11:05
11:05